Nationally representative surveys show gradual shifting of overweight and obesity towards poor and less-educated women of reproductive age in Nepal.


Journal

Journal of biosocial science
ISSN: 1469-7599
Titre abrégé: J Biosoc Sci
Pays: England
ID NLM: 0177346

Informations de publication

Date de publication:
03 2021
Historique:
pubmed: 29 3 2020
medline: 7 7 2021
entrez: 29 3 2020
Statut: ppublish

Résumé

Overweight and obesity are considered major public health concerns all over the world. They have the potential to increase the risk of developing non-communicable diseases in reproductive age women, increasing their risk of pregnancy related complications and adverse birth outcome. This study was carried out to identify the trend of prevalence of overweight and obesity, along with their determinants, among reproductive age women (15-49 years) in Nepal. Data were taken from the nationally representative 2006, 2011 and 2016 Nepal Demographic and Health Surveys (NDHSs). Women were considered to be overweight or obese when their BMI was 23.0-27.5 kg/m2 or ≥27.5 kg/m2, respectively. Univariate, bivariate and multivariate analyses were performed, with significance taken at p<0.05. The prevalences of overweight and obesity both showed rising trends in women of reproductive age in Nepal from 2006 to 2016, particularly among those with no education, only primary education and poor women. The presence of overweight and obesity was found to be significantly associated with the sample women's age, educational status, wealth index, place of residence, ecological zone, developmental region, number of household members, marital status and ethnicity. In 2016 one in every three women of reproductive age in Nepal was either overweight or obese. As overweight and obesity have detrimental effects on women's health, the Government of Nepal, in collaboration with other government and non-government organizations, should take action to halt the rising trends in overweight and obesity in the country.

Identifiants

pubmed: 32216862
pii: S0021932020000152
doi: 10.1017/S0021932020000152
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

214-232

Auteurs

Ipsita Sutradhar (I)

Centre for Non-Communicable Diseases and Nutrition (CNCDN), BRAC James P. Grant School of Public Health, BRAC University, Dhaka, Bangladesh.
Centre of Excellence for Science of Implementation & Scale Up (CoE-SISU), BRAC James P. Grant School of Public Health, BRAC University, Dhaka, Bangladesh.

Tahmina Akter (T)

Institute of Statistical Research and Training, University of Dhaka, Dhaka, Bangladesh.

Mehedi Hasan (M)

Centre for Non-Communicable Diseases and Nutrition (CNCDN), BRAC James P. Grant School of Public Health, BRAC University, Dhaka, Bangladesh.
Centre of Excellence for Science of Implementation & Scale Up (CoE-SISU), BRAC James P. Grant School of Public Health, BRAC University, Dhaka, Bangladesh.

Rajat Das Gupta (R)

Centre for Non-Communicable Diseases and Nutrition (CNCDN), BRAC James P. Grant School of Public Health, BRAC University, Dhaka, Bangladesh.
Centre of Excellence for Science of Implementation & Scale Up (CoE-SISU), BRAC James P. Grant School of Public Health, BRAC University, Dhaka, Bangladesh.
Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.

Hemraj Joshi (H)

Child Health Program Office, Lifeline Nepal, Kathmandu, Nepal.

Mohammad Rifat Haider (MR)

Department of Social and Public Health, College of Health Sciences and Professions, Ohio University, Athens, OH, USA.

Malabika Sarker (M)

Centre for Non-Communicable Diseases and Nutrition (CNCDN), BRAC James P. Grant School of Public Health, BRAC University, Dhaka, Bangladesh.
Centre of Excellence for Science of Implementation & Scale Up (CoE-SISU), BRAC James P. Grant School of Public Health, BRAC University, Dhaka, Bangladesh.
Institute of Public Health, University of Heidelberg, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH